Phase 2 Readouts
Phase 2 trials test drug efficacy in 100-300 patients with the target condition. Positive Phase 2 data validates the drug mechanism and sets the stage for pivotal Phase 3 trials.
10 phase 2 readouts tracked, next on Dec 31, 2026. Event dates and source records are shown with their available source context.
Phase2_Topline: Regulation FD Disclosure.: On July 27, 2026, MapLight Therapeutics, Inc. (the "Company") will hold a conference call to discuss the topline results from ZEPHYR, a Phase 2 trial
MapLight Therapeutics, Inc. (MPLT)
Phase2_Topline: Regulation FD Disclosure.: On May 27, 2026, Apogee Therapeutics, Inc. (the "Company")
Apogee Therapeutics, Inc. (APGE)
Phase2_Topline: Zenas BioPharma Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Zenas BioPharma, Inc. (ZBIO)
Phase2_Topline: Climb Bio: 'Buy' On Budoprutug Phase 2 Advancement pMN And Expansions Underway
Climb Bio, Inc. (CLYM)
Phase2_Topline: 0001193125-26-281817
Kymera Therapeutics, Inc. (KYMR)
Phase2_Topline: Tvardi Therapeutics Announces Fourth Quarter and Full-Year 2025 Results and Provides Business Update
Tvardi Therapeutics, Inc. (TVRD)
Phase2_Topline: IGC Pharma Reports Q2 2026 Results as CALMA Alzheimer's Trial Moves Within Six Randomizations of Enrollment Closure
IGC Pharma, Inc. (IGC)
Phase2_Topline: Tvardi Therapeutics Announces First Quarter 2026 Results and Provides Business Update
Tvardi Therapeutics, Inc. (TVRD)
Phase2_Topline: Veru Reports Fiscal 2026 Third Quarter Financial Results and Phase 2b PLATEAU Clinical Trial Progress
VERU INC. (VERU)
Phase2_Topline: Adagene Reports Six Months 2026 Financial Results and Provides Corporate Updates
Adagene Inc. (ADAG)
Frequently asked questions
What does a Phase 2 readout show?
Phase 2 trials (typically 100-300 patients) provide the first efficacy and dose-finding signals in the target patient population.
Why do investors watch Phase 2 data?
Positive Phase 2 results validate a drug's mechanism and de-risk the move into pivotal Phase 3 trials, often re-rating early-stage biotech valuations.
Are Phase 2 readout dates exact?
They are estimated windows based on enrollment and completion timelines; BioSniper updates them as company guidance changes.
Learn more
Biotech Clinical Trial Phases Explained: What Investors Need to Know
A comprehensive guide to Phase 1, Phase 2, and Phase 3 clinical trials — what happens at each stage, success rates, and what results mean for biotech stocks.
Phase 3 Readouts: Match the Estimand to the Reported Treatment Effect
Audit a Phase 3 result using population, treatment, endpoint, intercurrent events and summary measure. Check the analysis plan before interpreting a p-value or hazard ratio.
Breakthrough Therapy: Read the Preliminary Evidence and Scope
Read the preliminary clinical evidence and exact studied use behind Breakthrough Therapy designation without treating it as approval or a success probability.
Key terms
From catalyst type to protocol condition
Decide when this event type should matter
Set the timing, confidence, company, drug, trial, and financing conditions that must hold before this catalyst changes a decision.